Mechanisms of genetically-based resistance to malaria

Gene

Volumn 467, Issue 1-2, 2010, Pages 1-12

  López, Carolina ^a,b,c   Saravia, Carolina ^a,b   Gomez, Andromeda ^a   Hoebeke, Johan ^d   Patarroyo, Manuel A ^a,b  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

^c UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^d CNRS   (France)

Author keywords

Erythrocyte polymorphism; Hemoglobinopathy; Malaria; Natural resistance

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; HEMOGLOBIN C; HEMOGLOBIN E; INDUCIBLE NITRIC OXIDE SYNTHASE; LEUKOCYTE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; COMPLEMENT RECEPTOR;

ALLELE; ALPHA THALASSEMIA; BABOON; CHROMOSOME 5Q; CHROMOSOME POLYMORPHISM; ELLIPTOCYTOSIS; GENE EXPRESSION; HEMOGLOBINOPATHY; HUMAN; MALARIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW; SICKLE CELL; CHEMICAL STRUCTURE; ERYTHROCYTE; GENETIC POLYMORPHISM; GENETICS; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; SICKLE CELL TRAIT; THALASSEMIA;

ERYTHROCYTES; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOGLOBINOPATHIES; HUMANS; IMMUNITY, INNATE; MALARIA; MODELS, MOLECULAR; POLYMORPHISM, GENETIC; RECEPTORS, COMPLEMENT; SICKLE CELL TRAIT; THALASSEMIA;

PLASMODIUM PARASITES;

EID: 77956880216     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2010.07.008     Document Type: Review

References (171)

1. Abbas A.K. Cellular and Molecular Immunology 2003, Saunders, Philadelphia. 5th ed.
2. Abu-Zeid Y.A., Abdulhadi N.H., Hviid L., Theander T.G., Saeed B.O., Jepsen S., Jensen J.B., Bayoumi R.A. Lymphoproliferative responses to Plasmodium falciparum antigens in children with and without the sickle cell trait. Scand. J. Immunol. 1991, 34:237-242.
3. Ackerman H., Usen S., Jallow M., Sisay-Joof F., Pinder M., Kwiatkowski D.P. A comparison of case-control and family-based association methods: the example of sickle-cell and malaria. Ann. Hum. Genet. 2005, 69:559-565.
4. Agarwal A., Guindo A., Cissoko Y., Taylor J.G., Coulibaly D., Kone A., Kayentao K., Djimde A., Plowe C.V., Doumbo O., Wellems T.E., Diallo D. Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S. Blood 2000, 96:2358-2363.
5. Aidoo M., Terlouw D.J., Kolczak M.S., McElroy P.D., ter Kuile F.O., Kariuki S., Nahlen B.L., Lal A.A., Udhayakumar V. Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet 2002, 359:1311-1312.
6. Akide-Ndunge O.B., Ayi K., Arese P. The Haldane malaria hypothesis: facts, artifacts, and a prophecy. Redox Rep. 2003, 8:311-316.
7. Allen S.J., O'Donnell A., Alexander N.D., Alpers M.P., Peto T.E., Clegg J.B., Weatherall D.J. Alpha+-Thalassemia protects children against disease caused by other infections as well as malaria. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:14736-14741.
8. Allen S.J., O'Donnell A., Alexander N.D., Mgone C.S., Peto T.E., Clegg J.B., Alpers M.P., Weatherall D.J. Prevention of cerebral malaria in children in Papua New Guinea by southeast Asian ovalocytosis band 3. Am. J. Trop. Med. Hyg. 1999, 60:1056-1060.
9. Allison A.C. Polymorphism and natural selection in human populations. Cold Spring Harb. Symp. Quant. Biol. 1964, 29:137-149.
10. Ayi K., Turrini F., Piga A., Arese P. Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait. Blood 2004, 104:3364-3371.
11. Ayi K., Min-Oo G., Serghides L., Crockett M., Kirby-Allen M., Quirt I., Gros P., Kain K.C. Pyruvate kinase deficiency and malaria. N. Engl. J. Med. 2008, 358:1805-1810.
12. Babbitt B.P., Allen P.M., Matsueda G., Haber E., Unanue E.R. Binding of immunogenic peptides to Ia histocompatibility molecules. Nature 1985, 317:359-361.
13. Bayley J.P., Ottenhoff T.H., Verweij C.L. Is there a future for TNF promoter polymorphisms?. Genes Immun. 2004, 5:315-329.
14. Beutler E. G6PD deficiency. Blood 1994, 84:3613-3636.
15. Bjorkman P.J., Parham P. Structure, function, and diversity of class I major histocompatibility complex molecules. Annu. Rev. Biochem. 1990, 59:253-288.
16. Bjorkman P.J., Saper M.A., Samraoui B., Bennett W.S., Strominger J.L., Wiley D.C. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987, 329:506-512.
17. Boots M., Haraguchi Y. The evolution of costly resistance in host-parasite systems. Am. Nat. 1999, 153:359-370.
18. Bradbury J. Haemoglobin C protection against malaria. Lancet 2001, 358:1702.
19. Brockelman C.R., Wongsattayanont B., Tan-ariya P., Fucharoen S. Thalassemic erythrocytes inhibit in vitro growth of Plasmodium falciparum. J. Clin. Microbiol. 1987, 25:56-60.
20. Brown J., Smalley M.E. Specific antibody-dependent cellular cytotoxicity in human malaria. Clin. Exp. Immunol. 1980, 41:423-429.
21. Brown J.H., Jardetzky T.S., Gorga J.C., Stern L.J., Urban R.G., Strominger J.L., Wiley D.C. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993, 364:33-39.
22. Bruce L. Mutations in band 3 and cation leaky red cells. Blood Cells Mol. Dis. 2006, 36:331-336.
23. Bunyaratvej A., Butthep P., Sae-Ung N., Fucharoen S., Yuthavong Y. Reduced deformability of thalassemic erythrocytes and erythrocytes with abnormal hemoglobins and relation with susceptibility to Plasmodium falciparum invasion. Blood 1992, 79:2460-2463.
24. Burgner D., Xu W., Rockett K., Gravenor M., Charles I.G., Hill A.V., Kwiatkowski D. Inducible nitric oxide synthase polymorphism and fatal cerebral malaria. Lancet 1998, 352:1193-1194.
25. Buus S., Sette A., Colon S.M., Jenis D.M., Grey H.M. Isolation and characterization of antigen-Ia complexes involved in T cell recognition. Cell 1986, 47:1071-1077.
26. Cabrera G., Cot M., Migot-Nabias F., Kremsner P.G., Deloron P., Luty A.J. The sickle cell trait is associated with enhanced immunoglobulin G antibody responses to Plasmodium falciparum variant surface antigens. J. Infect. Dis. 2005, 191:1631-1638.
27. Cappadoro M., Giribaldi G., O'Brien E., Turrini F., Mannu F., Ulliers D., Simula G., Luzzatto L., Arese P. Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood 1998, 92:2527-2534.
28. Carvalho L.J., Daniel-Ribeiro C.T., Goto H. Malaria vaccine: candidate antigens, mechanisms, constraints and prospects. Scand. J. Immunol. 2002, 56:327-343.
29. Celada A., Cruchaud A., Perrin L.H. Opsonic activity of human immune serum on in vitro phagocytosis of Plasmodium falciparum infected red blood cells by monocytes. Clin. Exp. Immunol. 1982, 47:635-644.
30. Chan M., Sim T.S. Functional analysis, overexpression, and kinetic characterization of pyruvate kinase from Plasmodium falciparum. Biochem. Biophys. Res. Commun. 2005, 326:188-196.
31. Chartrain N.A., Geller D.A., Koty P.P., Sitrin N.F., Nussler A.K., Hoffman E.P., Billiar T.R., Hutchinson N.I., Mudgett J.S. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J. Biol. Chem. 1994, 269:6765-6772.
32. Chebloune Y., Pagnier J., Trabuchet G., Faure C., Verdier G., Labie D., Nigon V. Structural analysis of the 5' flanking region of the beta-globin gene in African sickle cell anemia patients: further evidence for three origins of the sickle cell mutation in Africa. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:4431-4435.
33. Chitnis C.E., Miller L.H. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J. Exp. Med. 1994, 180:497-506.
34. Cholera R., Brittain N.J., Gillrie M.R., Lopera-Mesa T.M., Diakite S.A., Arie T., Krause M.A., Guindo A., Tubman A., Fujioka H., Diallo D.A., Doumbo O.K., Ho M., Wellems T.E., Fairhurst R.M. Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:991-996.
35. Chotivanich K., Udomsangpetch R., Pattanapanyasat K., Chierakul W., Simpson J., Looareesuwan S., White N. Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P falciparum malaria. Blood 2002, 100:1172-1176.
36. Cockburn I.A., Mackinnon M.J., O'Donnell A., Allen S.J., Moulds J.M., Baisor M., Bockarie M., Reeder J.C., Rowe J.A. A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:272-277.
37. Coia V., Juliger S., Mordmuller B., Kreidenweis A., Stroh A.L., Ortega C., Vindigni A., Dengjel J., Lukyanov D.V., Destro-Bisol G., Fedorov A., Podgornaya O.I., Kun J.F. Analysis of polymorphic sites in the promoter of the nitric oxide synthase 2 gene. Biochem. Biophys. Res. Commun. 2005, 335:1123-1131.
38. Cooke B.M., Berendt A.R., Craig A.G., MacGregor J., Newbold C.I., Nash G.B. Rolling and stationary cytoadhesion of red blood cells parasitized by Plasmodium falciparum: separate roles for ICAM-1, CD36 and thrombospondin. Br. J. Haematol. 1994, 87:162-170.
39. Cooke B.M., Mohandas N., Coppel R.L. Malaria and the red blood cell membrane. Semin. Hematol. 2004, 41:173-188.
40. Cortes A., Mellombo M., Mgone C.S., Beck H.P., Reeder J.C., Cooke B.M. Adhesion of Plasmodium falciparum-infected red blood cells to CD36 under flow is enhanced by the cerebral malaria-protective trait South-East Asian ovalocytosis. Mol. Biochem. Parasitol. 2005, 142:252-257.
41. Das S.K., Talukder G. A review on the origin and spread of deleterious mutants of the beta-globin gene in Indian populations. Homo 2001, 52:93-109.
42. Dausset J. The major histocompatibility complex in man. Science 1981, 213:1469-1474.
43. de Brevern A.G., Wong H., Tournamille C., Colin Y., Le Van Kim C., Etchebest C. A structural model of a seven-transmembrane helix receptor: the Duffy antigen/receptor for chemokine (DARC). Biochim. Biophys. Acta 2005, 1724:288-306.
44. Delaunay J. The molecular basis of hereditary red cell membrane disorders. Blood Rev. 2007, 21:1-20.
45. Duffy P.E., Fried M. Red blood cells that do and red blood cells that don't: how to resist a persistent parasite. Trends Parasitol. 2006, 22:99-101.
46. Durand P.M., Coetzer T.L. Pyruvate kinase deficiency protects against malaria in humans. Haematologica 2008, 93:939-940.
47. Fairhurst R.M., Baruch D.I., Brittain N.J., Ostera G.R., Wallach J.S., Hoang H.L., Hayton K., Guindo A., Makobongo M.O., Schwartz O.M., Tounkara A., Doumbo O.K., Diallo D.A., Fujioka H., Ho M., Wellems T.E. Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria. Nature 2005, 435:1117-1121.
48. Falk K., Rotzschke O., Stevanovic S., Jung G., Rammensee H.G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991, 351:290-296.
49. Flint J., Harding R.M., Boyce A.J., Clegg J.B. The population genetics of the haemoglobinopathies. Baillieres Clin. Haematol. 1998, 11:1-51.
50. Flori L., Kumulungui B., Aucan C., Esnault C., Traore A.S., Fumoux F., Rihet P. Linkage and association between Plasmodium falciparum blood infection levels and chromosome 5q31-q33. Genes Immun. 2003, 4:265-268.
51. Frank J.E. Diagnosis and management of G6PD deficiency. Am. Fam. Physician 2005, 72:1277-1282.
52. Fremont D.H., Matsumura M., Stura E.A., Peterson P.A., Wilson I.A. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science 1992, 257:919-927.
53. Friedman M.J. Erythrocytic mechanism of sickle cell resistance to malaria. Proc. Natl. Acad. Sci. U. S. A. 1978, 75:1994-1997.
54. Friedman M.J., Roth E.F., Nagel R.L., Trager W. The role of hemoglobins C, S, and Nbalt in the inhibition of malaria parasite development in vitro. Am. J. Trop. Med. Hyg. 1979, 28:777-780.
55. Gabriel J., Berzins K. Specific lysis of Plasmodium yoelii infected mouse erythrocytes with antibody and complement. Clin. Exp. Immunol. 1983, 52:129-134.
56. Gallagher P.G. Red cell membrane disorders. Hematology Am. Soc. Hematol. Educ. Program 2005, 1:13-18.
57. Ganczakowski M., Bowden D.K., Maitland K., Williams T.N., O'Shaughnessy D., Viji J., Lucassen A., Clegg J.B., Weatherall D.J. Thalassaemia in Vanuatu, south-west Pacific: frequency and haematological phenotypes of young children. Br. J. Haematol. 1995, 89:485-495.
58. Garcia A., Marquet S., Bucheton B., Hillaire D., Cot M., Fievet N., Dessein A.J., Abel L. Linkage analysis of blood Plasmodium falciparum levels: interest of the 5q31-q33 chromosome region. Am. J. Trop. Med. Hyg. 1998, 58:705-709.
59. Gelpi A.P., King M.C. Association of Duffy blood groups with the sickle cell trait. Hum. Genet. 1976, 32:65-68.
60. Genton B., al-Yaman F., Mgone C.S., Alexander N., Paniu M.M., Alpers M.P., Mokela D. Ovalocytosis and cerebral malaria. Nature 1995, 378:564-565.
61. Gilbert S.C., Plebanski M., Gupta S., Morris J., Cox M., Aidoo M., Kwiatkowski D., Greenwood B.M., Whittle H.C., Hill A.V. Association of malaria parasite population structure, HLA, and immunological antagonism. Science 1998, 279:1173-1177.
62. Guindo A., Fairhurst R.M., Doumbo O.K., Wellems T.E., Diallo D.A. X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. PLoS Med. 2007, 4:516-522.
63. Haldane J.B.S. The rate of mutation of human genes. Hereditas Suppl. 1949, 35:267-273.
64. Hamblin M.T., Di Rienzo A. Detection of the signature of natural selection in humans: evidence from the Duffy blood group locus. Am. J. Hum. Genet. 2000, 66:1669-1679.
65. Hans D., Pattnaik P., Bhattacharyya A., Shakri A.R., Yazdani S.S., Sharma M., Choe H., Farzan M., Chitnis C.E. Mapping binding residues in the Plasmodium vivax domain that binds Duffy antigen during red cell invasion. Mol. Microbiol. 2005, 55:1423-1434.
66. Hardy D.A., Bell J.I., Long E.O., Lindsten T., McDevitt H.O. Mapping of the class II region of the human major histocompatibility complex by pulsed-field gel electrophoresis. Nature 1986, 323:453-455.
67. Hill A.V., Allsopp C.E., Kwiatkowski D., Anstey N.M., Twumasi P., Rowe P.A., Bennett S., Brewster D., McMichael A.J., Greenwood B.M. Common west African HLA antigens are associated with protection from severe malaria. Nature 1991, 352:595-600.
68. Hill A.V., Elvin J., Willis A.C., Aidoo M., Allsopp C.E., Gotch F.M., Gao X.M., Takiguchi M., Greenwood B.M., Townsend A.R., et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992, 360:434-439.
69. Hobbs M.R., Udhayakumar V., Levesque M.C., Booth J., Roberts J.M., Tkachuk A.N., Pole A., Coon H., Kariuki S., Nahlen B.L., Mwaikambo E.D., Lal A.L., Granger D.L., Anstey N.M., Weinberg J.B. A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet 2002, 360:1468-1475.
70. Hutagalung R., Wilairatana P., Looareesuwan S., Brittenham G.M., Aikawa M., Gordeuk V.R. Influence of hemoglobin E trait on the severity of Falciparum malaria. J. Infect. Dis. 1999, 179:283-286.
71. Hutagalung R., Wilairatana P., Looareesuwan S., Brittenham G.M., Gordeuk V.R. Influence of hemoglobin E trait on the antimalarial effect of artemisinin derivatives. J. Infect. Dis. 2000, 181:1513-1516.
72. Iwamoto S., Li J., Sugimoto N., Okuda H., Kajii E. Characterization of the Duffy gene promoter: evidence for tissue-specific abolishment of expression in Fy(a-b-) of black individuals. Biochem. Biophys. Res. Commun. 1996, 222:852-859.
73. Jardetzky T.S., Gorga J.C., Busch R., Rothbard J., Strominger J.L., Wiley D.C. Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding. EMBO J. 1990, 9:1797-1803.
74. Jarolim P., Palek J., Amato D., Hassan K., Sapak P., Nurse G.T., Rubin H.L., Zhai S., Sahr K.E., Liu S.C. Deletion in erythrocyte band 3 gene in malaria-resistant Southeast Asian ovalocytosis. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:11022-11026.
75. Jongwutiwes S., Putaporntip C., Iwasaki T., Ferreira M.U., Kanbara H., Hughes A.L. Mitochondrial genome sequences support ancient population expansion in Plasmodium vivax. Mol. Biol. Evol. 2005, 22:1733-1739.
76. Katz D.H., Hamaoka T., Dorf M.E., Benacerraf B. Cell interactions between histoincompatible T and B lymphocytes. The H-2 gene complex determines successful physiologic lymphocyte interactions. Proc. Natl. Acad. Sci. U. S. A. 1973, 70:2624-2628.
77. Kidson C., Lamont G., Saul A., Nurse G.T. Ovalocytic erythrocytes from Melanesians are resistant to invasion by malaria parasites in culture. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:5829-5832.
78. King C.L., Malhotra I., Wamachi A., Kioko J., Mungai P., Wahab S.A., Koech D., Zimmerman P., Ouma J., Kazura J.W. Acquired immune responses to Plasmodium falciparum merozoite surface protein-1 in the human fetus. J. Immunol. 2002, 168:356-364.
79. Knight J.C., Udalova I., Hill A.V., Greenwood B.M., Peshu N., Marsh K., Kwiatkowski D. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat. Genet. 1999, 22:145-150.
80. Koella J.C., Boete C. A model for the coevolution of immunity and immune evasion in vector-borne diseases with implications for the epidemiology of malaria. Am. Nat. 2003, 161:698-707.
81. Kremsner P.G., Winkler S., Wildling E., Prada J., Bienzle U., Graninger W., Nussler A.K. High plasma levels of nitrogen oxides are associated with severe disease and correlate with rapid parasitological and clinical cure in Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 1996, 90:44-47.
82. Kun J.F., Mordmuller B., Lell B., Lehman L.G., Luckner D., Kremsner P.G. Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet 1998, 351:265-266.
83. Kun J.F., Mordmuller B., Perkins D.J., May J., Mercereau-Puijalon O., Alpers M., Weinberg J.B., Kremsner P.G. Nitric oxide synthase 2(Lambarene) (G-954C), increased nitric oxide production, and protection against malaria. J. Infect. Dis. 2001, 184:330-336.
84. Kwiatkowski D. Genetic susceptibility to malaria getting complex. Curr. Opin. Genet. Dev. 2000, 10:320-324.
85. Kwiatkowski D.P. How malaria has affected the human genome and what human genetics can teach us about malaria. Am. J. Hum. Genet. 2005, 77:171-192.
86. Lapoumeroulie C., Dunda O., Ducrocq R., Trabuchet G., Mony-Lobe M., Bodo J.M., Carnevale P., Labie D., Elion J., Krishnamoorthy R. A novel sickle cell mutation of yet another origin in Africa: the Cameroon type. Hum. Genet. 1992, 89:333-337.
87. Levesque M.C., Hobbs M.R., O'Loughlin C.W., Chancellor J.A., Chen Y., Tkachuk A.N., Booth J., Patch K.B., Allgood S., Pole A.R., Fernandez C.A., Mwaikambo E.D., Mutabingwa T.K., Fried M., Sorensen B., Duffy P.E., Granger D.L., Anstey N.M., Weinberg J.B. Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes. Hum. Genet. 2010, 127:163-182.
88. Lum J.K., Kaneko A., Tanabe K., Takahashi N., Bjorkman A., Kobayakawa T. Malaria dispersal among islands: human mediated Plasmodium falciparum gene flow in Vanuatu, Melanesia. Acta Trop. 2004, 90:181-185.
89. Luzzi G.A., Merry A.H., Newbold C.I., Marsh K., Pasvol G., Weatherall D.J. Surface antigen expression on Plasmodium falciparum-infected erythrocytes is modified in alpha- and beta-thalassemia. J. Exp. Med. 1991, 173:785-791.
90. Mason P.M., Parham P. HLA class I region sequences, 1998. Tissue Antigens 1998, 51:417-466.
91. Matsumura M., Fremont D.H., Peterson P.A., Wilson I.A. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 1992, 257:927-934.
92. Mehta A., Mason P.J., Vulliamy T.J. Glucose-6-phosphate dehydrogenase deficiency. Baillieres Best Pract. Res. Clin. Haematol. 2000, 13:21-38.
93. Michon P., Woolley I., Wood E.M., Kastens W., Zimmerman P.A., Adams J.H. Duffy-null promoter heterozygosity reduces DARC expression and abrogates adhesion of the P. vivax ligand required for blood-stage infection. FEBS Lett. 2001, 495:111-114.
94. Miller L.H. Impact of malaria on genetic polymorphism and genetic diseases in Africans and African Americans. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:2415-2419.
95. Miller L.H., Mason S.J., Clyde D.F., McGinniss M.H. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N. Engl. J. Med. 1976, 295:302-304.
96. Miller J., Golenser J., Spira D.T., Kosower N.S. Plasmodium falciparum: thiol status and growth in normal and glucose-6-phosphate dehydrogenase deficient human erythrocytes. Exp. Parasitol. 1984, 57:239-247.
97. Min-Oo G., Gros P. Erythrocyte variants and the nature of their malaria protective effect. Cell. Microbiol. 2005, 7:753-763.
98. Min-Oo G., Fortin A., Tam M.F., Nantel A., Stevenson M.M., Gros P. Pyruvate kinase deficiency in mice protects against malaria. Nat. Genet. 2003, 35:357-362.
99. Mockenhaupt F.P., May J., Bergqvist Y., Meyer C.G., Falusi A.G., Bienzle U. Evidence for a reduced effect of chloroquine against Plasmodium falciparum in alpha-thalassaemic children. Trop. Med. Int. Health 2001, 6:102-107.
100. Mockenhaupt F.P., Ehrhardt S., Cramer J.P., Otchwemah R.N., Anemana S.D., Goltz K., Mylius F., Dietz E., Eggelte T.A., Bienzle U. Hemoglobin C and resistance to severe malaria in Ghanaian children. J. Infect. Dis. 2004, 190:1006-1009.
101. Mockenhaupt F.P., Ehrhardt S., Gellert S., Otchwemah R.N., Dietz E., Anemana S.D., Bienzle U. Alpha(+)-thalassemia protects African children from severe malaria. Blood 2004, 104:2003-2006.
102. Mockenhaupt F.P., Ehrhardt S., Otchwemah R., Eggelte T.A., Anemana S.D., Stark K., Bienzle U., Kohne E. Limited influence of haemoglobin variants on Plasmodium falciparum msp1 and msp2 alleles in symptomatic malaria. Trans. R. Soc. Trop. Med. Hyg. 2004, 98:302-310.
103. Modiano D., Petrarca V., Sirima B.S., Nebie I., Diallo D., Esposito F., Coluzzi M. Different response to Plasmodium falciparum malaria in west African sympatric ethnic groups. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:13206-13211.
104. Modiano D., Luoni G., Sirima B.S., Simpore J., Verra F., Konate A., Rastrelli E., Olivieri A., Calissano C., Paganotti G.M., D'Urbano L., Sanou I., Sawadogo A., Modiano G., Coluzzi M. Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature 2001, 414:305-308.
105. Mohan K., Stevenson M.M. Acquired immunity to asexual blood stages. Malaria: Parasite Biology, Pathogenesis and Protection 1998, 467-493. ASM press, Washington, D. C. I.W. Sherman (Ed.).
106. Mohandas N., Lie-Injo L.E., Friedman M., Mak J.W. Rigid membranes of Malayan ovalocytes: a likely genetic barrier against malaria. Blood 1984, 63:1385-1392.
107. Nagayasu E., Ito M., Akaki M., Nakano Y., Kimura M., Looareesuwan S., Aikawa M. CR1 density polymorphism on erythrocytes of falciparum malaria patients in Thailand. Am. J. Trop. Med. Hyg. 2001, 64:1-5.
108. Nagel R.L., Ranney H.M. Genetic epidemiology of structural mutations of the beta-globin gene. Semin. Hematol. 1990, 27:342-359.
109. Nagel R.L., Raventos-Suarez C., Fabry M.E., Tanowitz H., Sicard D., Labie D. Impairment of the growth of Plasmodium falciparum in HbEE erythrocytes. J. Clin. Invest. 1981, 68:303-305.
110. Newbold C., Warn P., Black G., Berendt A., Craig A., Snow B., Msobo M., Peshu N., Marsh K. Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am. J. Trop. Med. Hyg. 1997, 57:389-398.
111. Oaks S.C., Mitchell V.S., Pearson G.W., Carpenter C.C.J. Malaria: Obstacles and Opportunities 1991.
112. Odeh M. The role of tumour necrosis factor-alpha in the pathogenesis of complicated falciparum malaria. Cytokine 2001, 14:11-18.
113. Ohashi J., Naka I., Patarapotikul J., Hananantachai H., Brittenham G., Looareesuwan S., Clark A.G., Tokunaga K. Extended linkage disequilibrium surrounding the hemoglobin E variant due to malarial selection. Am. J. Hum. Genet. 2004, 74:1198-1208.
114. Olson J.A., Nagel R.L. Synchronized cultures of P falciparum in abnormal red cells: the mechanism of the inhibition of growth in HbCC cells. Blood 1986, 67:997-1001.
115. Olumese P. Epidemiology and surveillance: changing the global picture of malaria-myth or reality?. Acta Trop. 2005, 95:265-269.
116. Pasvol G. Does alpha+-thalassaemia protect against malaria?. PLoS Med. 2006, 3:591-592.
117. Pasvol G., Weatherall D.J., Wilson R.J., Smith D.H., Gilles H.M. Fetal haemoglobin and malaria. Lancet 1976, 1:1269-1272.
118. Pasvol G., Weatherall D.J., Wilson R.J. Cellular mechanism for the protective effect of haemoglobin S against P. falciparum malaria. Nature 1978, 274:701-703.
119. Patrinos G.P., Kollia P., Papadakis M.N. Molecular diagnosis of inherited disorders: lessons from hemoglobinopathies. Hum. Mutat. 2005, 26:399-412.
120. Perkins D.J., Kremsner P.G., Schmid D., Misukonis M.A., Kelly M.A., Weinberg J.B. Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy gabonese children with prior mild or severe malaria. Infect. Immun. 1999, 67:4977-4981.
121. Phillips R.S. Current status of malaria and potential for control. Clin. Microbiol. Rev. 2001, 14:208-226.
122. Pieters J. MHC class II restricted antigen presentation. Curr. Opin. Immunol. 1997, 9:89-96.
123. Reinagel M.L., Gezen M., Ferguson P.J., Kuhn S., Martin E.N., Taylor R.P. The primate erythrocyte complement receptor (CR1) as a privileged site: binding of immunoglobulin G to erythrocyte CR1 does not target erythrocytes for phagocytosis. Blood 1997, 89:1068-1077.
124. Richer J., Chudley A.E. The hemoglobinopathies and malaria. Clin. Genet. 2005, 68:332-336.
125. Rihet P., Traore Y., Abel L., Aucan C., Traore-Leroux T., Fumoux F. Malaria in humans: Plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33. Am. J. Hum. Genet. 1998, 63:498-505.
126. Rihet P., Flori L., Tall F., Traore A.S., Fumoux F. Hemoglobin C is associated with reduced Plasmodium falciparum parasitemia and low risk of mild malaria attack. Hum. Mol. Genet. 2004, 13:1-6.
127. Roberts D.J., Williams T.N. Haemoglobinopathies and resistance to malaria. Redox Rep. 2003, 8:304-310.
128. Roth E.F., Raventos-Suarez C., Rinaldi A., Nagel R.L. Glucose-6-phosphate dehydrogenase deficiency inhibits in vitro growth of Plasmodium falciparum. Proc. Natl. Acad. Sci. U. S. A. 1983, 80:298-299.
129. Rothbard J.B., Taylor W.R. A sequence pattern common to T cell epitopes. EMBO J. 1988, 7:93-100.
130. Rowe J.A., Moulds J.M., Newbold C.I., Miller L.H.P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 1997, 388:292-295.
131. Ruwende C., Hill A. Glucose-6-phosphate dehydrogenase deficiency and malaria. J. Mol. Med. 1998, 76:581-588.
132. Ruwende C., Khoo S.C., Snow R.W., Yates S.N., Kwiatkowski D., Gupta S., Warn P., Allsopp C.E., Gilbert S.C., Peschu N., et al. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 1995, 376:246-249.
133. Silamut K., Phu N.H., Whitty C., Turner G.D., Louwrier K., Mai N.T., Simpson J.A., Hien T.T., White N.J. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am. J. Pathol. 1999, 155:395-410.
134. Singh S.K., Hora R., Belrhali H., Chitnis C.E., Sharma A. Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain. Nature 2006, 439:741-744.
135. Smith T.G., Ayi K., Serghides L., McAllister C.D., Kain K.C. Innate immunity to malaria caused by Plasmodium falciparum. Clin. Invest. Med. 2002, 25:262-272.
136. Sodeinde O., Clarke J.L., Vulliamy T.J., Luzzatto L., Mason P.J. Expression of Plasmodium falciparum G6PD-6PGL in laboratory parasites and in patient isolates in G6PD-deficient and normal Nigerian children. Br. J. Haematol. 2003, 122:662-668.
137. Stern L.J., Brown J.H., Jardetzky T.S., Gorga J.C., Urban R.G., Strominger J.L., Wiley D.C. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994, 368:215-221.
138. Stevenson M.M., Riley E.M. Innate immunity to malaria. Nat. Rev. Immunol. 2004, 4:169-180.
139. Stirnadel H.A., Stockle M., Felger I., Smith T., Tanner M., Beck H.P. Malaria infection and morbidity in infants in relation to genetic polymorphisms in Tanzania. Trop. Med. Int. Health 1999, 4:187-193.
140. Stoute J.A. Complement-regulatory proteins in severe malaria: too little or too much of a good thing?. Trends Parasitol. 2005, 21:218-223.
141. Suh K.N., Kain K.C., Keystone J.S. Malaria. Cmaj 2004, 170:1693-1702.
142. Tamasauskas D., Powell V., Saksela K., Yazdanbakhsh K. A homologous naturally occurring mutation in Duffy and CCR5 leading to reduced receptor expression. Blood 2001, 97:3651-3654.
143. Tchinda V.H., Tadem A.D., Tako E.A., Tene G., Fogako J., Nyonglema P., Sama G., Zhou A., Leke R.G. Severe malaria in Cameroonian children: correlation between plasma levels of three soluble inducible adhesion molecules and TNF-alpha. Acta Trop. 2007, 102:20-28.
144. Thathy V., Moulds J.M., Guyah B., Otieno W., Stoute J.A. Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya. Malar. J. 2005, 4:54.
145. Tournamille C., Filipe A., Badaut C., Riottot M.M., Longacre S., Cartron J.P., Le Van Kim C., Colin Y. Fine mapping of the Duffy antigen binding site for the Plasmodium vivax Duffy-binding protein. Mol. Biochem. Parasitol. 2005, 144:100-103.
146. Tung J., Primus A., Bouley A.J., Severson T.F., Alberts S.C., Wray G.A. Evolution of a malaria resistance gene in wild primates. Nature 2009, 460:388-391.
147. Turner G.D., Morrison H., Jones M., Davis T.M., Looareesuwan S., Buley I.D., Gatter K.C., Newbold C.I., Pukritayakamee S., Nagachinta B., et al. An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am. J. Pathol. 1994, 145:1057-1069.
148. Udeinya I.J., Miller L.H., McGregor I.A., Jensen J.B. Plasmodium falciparum strain-specific antibody blocks binding of infected erythrocytes to amelanotic melanoma cells. Nature 1983, 303:429-431.
149. VanBuskirk K.M., Sevova E., Adams J.H. Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:15754-15759.
150. Vento S., Cainelli F., Cesario F. Infections and thalassaemia. Lancet Infect. Dis. 2006, 6:226-233.
151. Wambua S., Mwangi T.W., Kortok M., Uyoga S.M., Macharia A.W., Mwacharo J.K., Weatherall D.J., Snow R.W., Marsh K., Williams T.N. The effect of alpha+-thalassaemia on the incidence of malaria and other diseases in children living on the coast of Kenya. PLoS Med. 2006, 3:643-651.
152. Wang D.N. Band 3 protein: structure, flexibility and function. FEBS Lett. 1994, 346:26-31.
153. Weatherall D.J. Common genetic disorders of the red cell and the 'malaria hypothesis'. Ann. Trop. Med. Parasitol. 1987, 81:539-548.
154. Weatherall D.J. Thalassaemia and malaria, revisited. Ann. Trop. Med. Parasitol. 1997, 91:885-890.
155. Weatherall D.J. Single gene disorders or complex traits: lessons from the thalassaemias and other monogenic diseases. Bmj 2000, 321:1117-1120.
156. Weatherall D.J. Genetic variation and susceptibility to infection: the red cell and malaria. Br. J. Haematol. 2008, 141:276-286.
157. Weatherall D.J., Provan A.B. Red cells I: inherited anaemias. Lancet 2000, 355:1169-1175.
158. Weatherall D.J., Miller L.H., Baruch D.I., Marsh K., Doumbo O.K., Casals-Pascual C., Roberts D.J. Malaria and the red cell. Hematology Am. Soc. Hematol. Educ. Program 2002, 1:35-57.
159. World Malaria Report 2008 2008, WHO and UNICEF.
160. Wilkinson R.J., Pasvol G. Host resistance to malaria runs into swampy water. Trends Microbiol. 1997, 5:213-215.
161. Willcox M., Bjorkman A., Brohult J. Falciparum malaria and beta-thalassaemia trait in northern Liberia. Ann. Trop. Med. Parasitol. 1983, 77:335-347.
162. Williams T.N. Red blood cell defects and malaria. Mol. Biochem. Parasitol. 2006, 149:121-127.
163. Williams T.N., Maitland K., Bennett S., Ganczakowski M., Peto T.E., Newbold C.I., Bowden D.K., Weatherall D.J., Clegg J.B. High incidence of malaria in alpha-thalassaemic children. Nature 1996, 383:522-525.
164. Williams T.N., Mwangi T.W., Roberts D.J., Alexander N.D., Weatherall D.J., Wambua S., Kortok M., Snow R.W., Marsh K. An immune basis for malaria protection by the sickle cell trait. PLoS Med. 2005, 2:e128.
165. Williams T.N., Mwangi T.W., Wambua S., Alexander N.D., Kortok M., Snow R.W., Marsh K. Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases. J. Infect. Dis. 2005, 192:178-186.
166. Williams T.N., Mwangi T.W., Wambua S., Peto T.E., Weatherall D.J., Gupta S., Recker M., Penman B.S., Uyoga S., Macharia A., Mwacharo J.K., Snow R.W., Marsh K. Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait. Nat. Genet. 2005, 37:1253-1257.
167. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:3195-3199.
168. Yuthavong Y., Wilairat P. Protection against malaria by thalassaemia and haemoglobin variants. Parasitol. Today 1993, 9:241-245.
169. Zanella A., Fermo E., Bianchi P., Chiarelli L.R., Valentini G. Pyruvate kinase deficiency: the genotype-phenotype association. Blood Rev. 2007, 21:217-231.
170. Zimmerman P.A., Woolley I., Masinde G.L., Miller S.M., McNamara D.T., Hazlett F., Mgone C.S., Alpers M.P., Genton B., Boatin B.A., Kazura J.W. Emergence of FA(null) in a Plasmodium vivax-endemic region of Papua New Guinea. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:13973-13977.
171. Zimmerman P.A., Fitness J., Moulds J.M., McNamara D.T., Kasehagen L.J., Rowe J.A., Hill A.V. CR1 Knops blood group alleles are not associated with severe malaria in the Gambia. Genes Immun. 2003, 4:368-373.